Spots Global Cancer Trial Database for recurrent and metastatic gastric cancer
Every month we try and update this database with for recurrent and metastatic gastric cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients | NCT03026881 | Recurrent and M... | Fluzoparib Apatinib Paclitaxel | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients | NCT03026881 | Recurrent and M... | Fluzoparib Apatinib Paclitaxel | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients | NCT03026881 | Recurrent and M... | Fluzoparib Apatinib Paclitaxel | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
